Inhibitory effect of galanin on dopamine-induced enhanced vasopressin secretion in rat neurohypophyseal tissue cultures

Regulatory Peptides

Volumn 110, Issue 1, 2002, Pages 17-23

  Galfi M ^a   Balaspiri L ^b   Toth R ^a   Pavo I ^b   Laszlo F ^c   Morschl, E ^c   Varga, Cs ^b   Laszlo F A ^b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Galanin regulation; Galanin dopamine interaction; Galantid; Neurohypophyseal tissue culture; Vasopressin

Indexed keywords

AMINO ACID DERIVATIVE; APOMORPHINE; DOPAMINE; GALANIN; GALANIN RECEPTOR; GALANTID; PROLYLLYSYLGLYCINE; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; VASOPRESSIN; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; DRUG DERIVATIVE; GALANTIDE; NEUROPEPTIDE RECEPTOR; SUBSTANCE P; VASOPRESSIN DERIVATIVE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; INCUBATION TIME; NEUROHYPOPHYSIS; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SUPERNATANT; VASOPRESSIN RELEASE; ANIMAL; CULTURE TECHNIQUE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG INTERACTION; HYPOTHALAMUS; KINETICS; MALE; METABOLISM; SECRETION; WISTAR RAT;

ANIMALS; APOMORPHINE; CULTURE TECHNIQUES; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; GALANIN; HYPOTHALAMUS; KINETICS; MALE; PITUITARY GLAND, POSTERIOR; RADIOIMMUNOASSAY; RATS; RATS, WISTAR; RECEPTORS, NEUROPEPTIDE; SUBSTANCE P; VASOPRESSINS;

EID: 18744372121     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(02)00112-X     Document Type: Article

References (69)

1. László F.A., Gálfi M., Jójárt I., Vecsernyés M., Laczi F., Maderschpach K. Neurohypophysis tissue culture as a model of hormonal activity of rat pituicytes. Thorn N.A., Vilhardt H., Treiman M. New aspects of morphology function and regulation, 4th Int. Conf. Neurohypophysis. 1989;87-89 Oxford Univ. Press, Copenhagen.
2. Janáky T., Szabó P., Kele Z., Baláspiri L., Varga C., Gálfi M.et al. Identification of oxytocin and vasopressin from neurohypophyseal cell culture. Rapid Commun. Mass Spectrom. 12:1998;1765-1768.
3. Boersma C.J., Sonnemans M.A., Van Leeuwen F.W. Immunoelectron microscopic demonstration of oxytocin and vasopressin in pituicytes and in nerve terminals forming synaptoid contacts with pituicytes in the rat neural lobe. Brain Res. 611:1993;117-129.
4. Pu L.P., Van Leeuwen F.W., Tracer H.L., Sonnemans M.A., Loh Y.P. Localization of vasopressin mRNA and immunoreactivity in pituicytes of pituitary stalk-transected rats after osmotic stimulation. Proc. Natl. Acad. Sci. U. S. A. 92:1995;10653-10657.
5. Tweedle C.D., Hatton G.I. Morphological adaptability at neurosecretory axonal endings on the neurovascular contact zone of the rat neurohypophysis. Neuroscience. 20:1987;241-246.
6. Tatemoto K., Rokaeus A., Jornvall H., McDonald T.J., Mutt V. Galanin - a novel biologically active peptide from porcine intestine. FEBS Lett. 164:1983;124-128.
7. Skofitsch G., Jacobowitz D.M. Immunohistochemical mapping of galanin-like neurons in the rat central nervous system. Peptides. 6:1985;509-546.
8. Melander T., Hokfelt T., Rokaeus A. Distribution of galaninlike immunoreactivity in the rat central nervous system. J. Comp. Neurol. 248:1986;475-517.
9. Palkovits M., Rokaeus A., Antoni F.A., Kiss A. Galanin in the hypothalamo-hypophyseal system. Neuroendocrinology. 46:1987;417-423.
10. Melander T., Hokfelt T., Rokaeus A., Cuello A.C., Oertel W.H., Verhofstad A.et al. Coexistence of galanin-like immunoreactivity with catecholamines, 5-hydroxytryptamine, GABA and neuropeptides in the rat CNS. J. Neurosci. 6:1986;3640-3654.
11. Rokaeus A., Young W.S. III, Mezey E. Galanin coexists with vasopressin in the normal rat hypothalamus and galanin's synthesis is increased in the Brattleboro (diabetes insipidus) rat. Neurosci. Lett. 90:1988;45-50.
12. Skofitsch G., Jacobowitz D.M., Amann R., Lembeck F. Galanin and vasopressin coexist in the rat hypothalamo-neurohypophyseal system. Neuroendocrinology. 49:1989;419-427.
13. Skofitsch G., Sills M.A., Jacobowitz D.M. Autoradiographic distribution of 125I-galanin binding sites in the rat central nervous system. Peptides. 7:1986;1029-1042.
14. Melander T., Kohler C., Nilsson S., Hokfelt T., Brodin E., Theodorsson E.et al. Autoradiographic quantitation and anatomical mapping of 125I-galanin binding sites in the rat central nervous system. J. Chem. Neuroanat. 1:1988;213-233.
15. Merchenthaler I., Lopez F.J., Negro-Vilar A. Anatomy and physiology of central galanin-containing pathways. Prog. Neurobiol. 40:1993;711-769.
16. Meister B., Cortes R., Villar M.J., Schalling M., Hokfelt T. Peptides and transmitter enzymes in hypothalamic magnocellular neurons after administration of hyperosmotic stimuli: comparison between messenger RNA and peptide/protein levels. Cell Tissue Res. 260:1990;279-297.
17. Kondo K., Murase T., Otake K., Ito M., Kurimoto F., Oiso Y. Galanin as a physiological neurotransmitter in hemodynamic control of arginine vasopressin release in rats. Neuroendocrinology. 57:1993;224-229.
18. Landry M., Roche D., Calas A. Short-term effects of centrally administered galanin on the hyperosmotically stimulated expression of vasopressin in the rat hypothalamus. An in situ hybridization and immunohistochemistry study. Neuroendocrinology. 61:1995;393-404.
19. Hatton G.I. Emerging concepts of structure-function dynamics in adult brain: the hypothalamo-neurohypophysial system. Prog. Neurobiol. 34:1990;437-504.
20. Falke N. Modulation of oxytocin and vasopressin release at the level of the neurohypophysis. Prog. Neurobiol. 36:1991;465-484.
21. Boersma C.J., Van Leeuwen F.W. Neuron-glia interactions in the release of oxytocin and vasopressin from the rat neural lobe: the role of opioids, other neuropeptides and their receptors. Neuroscience. 62:1994;1003-1020.
22. Gaymann W., Martin R. Immunoreactive galanin-like material in magnocellular hypothalamo-neurohypophysial neurones of the rat. Cell Tissue Res. 255:1989;139-147.
23. Koenig J.I., Hooi S., Gabriel S.M., Martin J.B. Potential involvement of galanin in the regulation of fluid homeostasis in the rat. Regul. Pept. 24:1989;81-86.
24. Shen J., Larm J.A., Gundlach A.L. Galanin-like peptide mRNA in neural lobe of rat pituitary. Increased expression after osmotic stimulation suggests a role for galanin-like peptide in neuron-glial interactions and/or neurosecretion. Neuroendocrinology. 73:2001;2-11.
25. Burazin T.C., Larm J.A., Gundlach A.L. Regulation by osmotic stimuli of galanin-R1 receptor expression in magnocellular neurones of the paraventricular and supraoptic nuclei of the rat. J. Neuroendocrinol. 13:2001;358-370.
26. Gálfi M., Janáky T., Tóth R., Prohászka G., Juhász A., Varga C.et al. Effects of dopamine and dopamine-active compounds on oxytocin and vasopressin production in rat neurohypophyseal tissue cultures. Regul. Pept. 98:2001;49-54.
27. Nordstrom O., Melander T., Hokfelt T., Bartfai T., Goldstein M. Evidence for an inhibitory effect of the peptide galanin on dopamine release from the rat median eminence. Neurosci. Lett. 73:1987;21-26.
28. Melander T., Fuxe K., Harfstrand A., Eneroth P., Hokfelt T. Effects of intraventricular injections of galanin on neuroendocrine functions in the male rat. Possible involvement of hypothalamic catecholamine neuronal systems. Acta Physiol. Scand. 131:1987;25-32.
29. Jansson A., Fuxe K., Eneroth P., Agnati L.F. Centrally administered galanin reduces dopamine utilization in the median eminence and increases dopamine utilization in the medial neostriatum of the male rat. Acta Physiol. Scand. 135:1989;199-200.
30. Kennedy P.G., Lisak R.P., Raff M.C. Cell type-specific markers for human glial and neuronal cells in culture. Lab. Invest. 43:1980;342-351.
31. Michler-Stuke A., Bottenstein J.E. Proliferation of glial-derived cells in defined media. J. Neurosci. Res. 7:1982;215-228.
32. Huszti Z., Rimanóczy A., Juhász A., Magyar K. Uptake, metabolism, and release of [3H]-histamine by glial cells in primary cultures of chicken cerebral hemispheres. Glia. 3:1990;159-168.
33. Julesz J., Gálfi M., Molnár J., Vecsernyés M. Central effects of tricyclic compounds on the endocrine system - an in vitro study. Prog. Brain Res. 91:1992;89-92.
34. Dogterom J., van Wimersma Greidanus T.B., De Wied D. Vasopressin in cerebrospinal fluid and plasma of man, dog, and rat. Am. J. Physiol. 234:1978;E463-E467.
35. Laczi F., Iványi T., Julesz J., Janáky T., László F.A. Plasma arginine-8-vasopressin responses to osmotic or histamine stimulation contribute to the differential diagnosis of central diabetes insipidus. Acta Endocrinol. (Copenh). 113:1986;168-174.
36. Hunter W.M., Greenwood F.C. Preparation of iodine 131 labelled human growth hormone of high specific activity. Nature. 194:1962;495-496.
37. Janáky T., Tóth G., Penke B., Kovács K., László F.A. Iodination of peptide hormones and purification of iodinated peptides by HPLC. J. Liq. Chromatogr. 5:1982;1499-1507.
38. Bauer F.E., Ginsberg L., Venetikou M., MacKay D.J., Burrin J.M., Bloom S.R. Growth hormone release in man induced by galanin, a new hypothalamic peptide. Lancet. 2:1986;192-195.
39. Bek T., Ottesen B., Fahrenkrug J. The effect of galanin, CGRP and ANP on spontaneous smooth muscle activity of rat uterus. Peptides. 9:1988;497-500.
40. Amiranoff B., Lorinet A.M., Lagny-Pourmir I., Laburthe M. Mechanism of galanin-inhibited insulin release. Occurrence of a pertussis-toxin-sensitive inhibition of adenylate cyclase. Eur. J. Biochem. 177:1988;147-152.
41. Schepp W., Prinz C., Tatge C., Hakanson R., Schusdziarra V., Classen M. Galanin inhibits gastrin release from isolated rat gastric G-cells. Am. J. Physiol. 258:1990;G596-G602.
42. Hooi S.C., Koenig J.I., Gabriel S.M., Maiter D., Martin J.B. Influence of thyroid hormone on the concentration of galanin in the rat brain and pituitary. Neuroendocrinology. 51:1990;351-356.
43. Crawley J.N., Austin M.C., Fiske S.M., Martin B., Consolo S., Berthold M.et al. Activity of centrally administered galanin fragments on stimulation of feeding behavior and on galanin receptor binding in the rat hypothalamus. J. Neurosci. 10:1990;3695-3700.
44. Gundlach A.L., Burazin T.C. Galanin-galanin receptor systems in the hypothalamic paraventricular and supraoptic nuclei. Some recent findings and future challenges. Ann. N.Y. Acad. Sci. 863:1998;241-251.
45. Cimini V. Galanin inhibits ACTH release in vitro and can be demonstrated immunocytochemically in dispersed corticotrophs. Exp. Cell Res. 228:1996;212-215.
46. Cai A., Bowers R.C., Moore J.P. Jr., Hyde J.F. Function of galanin in the anterior pituitary of estrogen-treated Fischer 344 rats: autocrine and paracrine regulation of prolactin secretion. Endocrinology. 139:1998;2452-2458.
47. Hyde J.F., Moore J.P. Jr., Cai A. Galanin in normal and hyperplastic anterior pituitary cells. From pituitary tumor cell lines to transgenic mice. Ann. N.Y. Acad. Sci. 863:1998;48-55.
48. Moore J.P. Jr., Cai A., Maley B.E., Jennes L., Hyde J.F. Galanin within the normal and hyperplastic anterior pituitary gland: localization, secretion, and functional analysis in normal and human growth hormone-releasing hormone transgenic mice. Endocrinology. 140:1999;1789-1799.
49. Liu S., Gao J. The relationship of galanin immunoreactive nerve fibers to glandular cells in the anterior pituitary in the monkey. Brain Res. 781:1998;112-118.
50. Hulting A.L., Meister B., Carlsson L., Hilding A., Isaksson O. On the role of the peptide galanin in regulation of growth hormone secretion. Acta Endocrinol. (Copenh). 125:1991;518-525.
51. Gaymann W., Falke N. Galanin lacks binding sites in the porcine pituitary and has no detectable effect on oxytocin and vasopressin release from rat neurosecretory endings. Neurosci. Lett. 112:1990;114-119.
52. Meister B., Hulting A.L., Uvnas-Moberg K., Hokfelt T. Galanin stimulates the release of cholecystokinin from nerve fibres in the pituitary neurointermediate lobe. Neuroreport. 4:1993;631-634.
53. Branchek T.A., Smith K.E., Gerald C., Walker M.W. Galanin receptor subtypes. Trends Pharmacol. Sci. 21:2000;109-117.
54. Mitchell V., Habert-Ortoli E., Epelbaum J., Aubert J.P., Beauvillain J.C. Semiquantitative distribution of galanin-receptor (GAL-R1) mRNA-containing cells in the male rat hypothalamus. Neuroendocrinology. 66:1997;160-172.
55. Landry M., Aman K., Hokfelt T. Galanin-R1 receptor in anterior and mid-hypothalamus: distribution and regulation. J. Comp. Neurol. 399:1998;321-340.
56. Mitchell V., Bouret S., Howard A.D., Beauvillain J.C. Expression of the galanin receptor subtype Gal-R2 mRNA in the rat hypothalamus. J. Chem. Neuroanat. 16:1999;265-277.
57. Depczynski B., Nichol K., Fathi Z., Iismaa T., Shine J., Cunningham A. Distribution and characterization of the cell types expressing GALR2 mRNA in brain and pituitary gland. Ann. N.Y. Acad. Sci. 863:1998;120-128.
58. Ohtaki T., Kumano S., Ishibashi Y., Ogi K., Matsui H., Harada M.et al. Isolation and cDNA cloning of a novel galanin-like peptide (GALP) from porcine hypothalamus. J. Biol. Chem. 274:1999;37041-37045.
59. Buijs R.M., Geffard M., Pool C.W., Hoorneman E.M. The dopaminergic innervation of the supraoptic and paraventricular nucleus. A light and electron microscopical study. Brain Res. 323:1984;65-72.
60. Lindvall O., Bjorklund A., Skagerberg G. Selective histochemical demonstration of dopamine terminal systems in rat di- and telencephalon: new evidence for dopaminergic innervation of hypothalamic neurosecretory nuclei. Brain Res. 306:1984;19-30.
61. Stefanini E., Devoto P., Marchisio A.M., Vernaleone F., Collu R. [3H]Spiroperidol binding to a putative dopaminergic receptor in rat pituitary gland. Life Sci. 26:1980;583-587.
62. Leibowitz S.F., Jhanwar-Uniyal M., Dvorkin B., Makman M.H. Distribution of alpha-adrenergic, beta-adrenergic and dopaminergic receptors in discrete hypothalamic areas of rat. Brain Res. 233:1982;97-114.
63. Holzbauer M., Sharman D.F., Godden U., Mann S.P., Stephens D.B. Effect of water and salt intake on pituitary catecholamines in the rat and domestic pig. Neuroscience. 5:1980;1959-1968.
64. Oki Y., Ohgo S., Yoshimi T. Effects of water deprivation and administration of hypertonic saline on dopamine concentrations in posterior pituitary and vasopressin release in rats. Brain Res. 348:1985;9-14.
65. Bridges T.E., Hillhouse E.W., Jones M.T. The effect of dopamine on neurohypophysial hormone release in vivo and from the rat neural lobe and hypothalamus in vitro. J. Physiol. 260:1976;647-666.
66. Forsling M.L., Williams H. Central effects of dopamine on vasopressin release in the normally hydrated and water-loaded rat. J. Physiol. 346:1984;49-59.
67. Bartfai T., Bedecs K., Land T., Langel U., Bertorelli R., Girotti P.et al. M-15: high-affinity chimeric peptide that blocks the neuronal actions of galanin in the hippocampus, locus coeruleus, and spinal cord. Proc. Natl. Acad. Sci. U. S. A. 88:1991;10961-10965.
68. Lindskog S., Ahren B., Land T., Langel U., Bartfai T. The novel high-affinity antagonist, galantide, blocks the galanin-mediated inhibition of glucose-induced insulin secretion. Eur. J. Pharmacol. 210:1992;183-188.
69. Ogren S.O., Pramanik A., Land T., Langel U. Differential effects of the putative galanin receptor antagonists M15 and M35 on striatal acetylcholine release. Eur. J. Pharmacol. 242:1993;59-64.